期刊文献+

细胞毒T淋巴细胞相关抗原4基因多态性与宫颈癌易感性的相关分析 被引量:6

Correlation analysis of genetic polymorphism of cytotoxic T-lymphocyte-associated antigen-4 and susceptibility to cervical cancer
在线阅读 下载PDF
导出
摘要 目的分析细胞毒T淋巴细胞抗原4(CTLA-4)基因-318 T/C、CT60 G/A、+49 G/A多态性与宫颈癌易感性之间的关系。方法以292例宫颈癌患者及355例健康对照者作为研究对象。抽提全血基因组DNA,PCR扩增后用直接测序法检测CTLA-4基因-318 T/C、CT60 G/A、+49 G/A多态性;密度梯度离心法分离外周血单个核细胞(PBMCs),MTT法检测携带不同基因型的PBMCs的增殖能力;ELISA法检测各组血清中IL-2、IL-4、TGF-β的表达水平。结果与CTLA-4-318TT基因型相比,CC基因型降低宫颈癌的发病风险(χ2=7.440,P<0.05);与CTLA-4 CT60GG基因型相比,AA基因型降低宫颈癌的发病风险(χ2=12.165,P<0.05);携带CTLA-4-318 T、CT60 G等位基因的宫颈癌患者增加(χ2分别为13.482和14.138,P均<0.05);而CTLA-4+49 G/A多态性与降低宫颈癌发病风险无关;携带CTLA-4-318TT、TC、CC的PBMCs细胞增殖率差异有统计学意义(F=13.842,P<0.05),而携带CT60、+49不同基因型的PBMCs细胞增殖率差异无统计学意义(F分别为0.578、0.150,P均>0.05)。CTLA-4-318 T/C、CT60 G/A、+49 G/A不同基因型间IL-2、IL-4和TGF-β的水平差异均有统计学意义(P均<0.05)。对宫颈癌组分层分析发现,CTLA-4-318 T/C基因多态性与患者的年龄、绝经与否、HPV感染因素无关(χ2分别为6.310、1.362和4.772,P均>0.05),而与肿瘤分期有关(χ2=18.555,P<0.05)。结论 CTLA-4-318 T/C基因多态性与宫颈癌的患病风险及病情进展有关,其机制可能与调节T细胞的增殖及TH细胞因子的分泌有关。 Objective To investigate the relationship between cytotoxic T-lymphocyte-associated antigen-4( CTLA-4) genotypes318 T / C,CT60 G / A and + 49 G / A and susceptibility to cervical cancer. Methods Peripheral blood samples from 292 patients with cervical cancer and 355 healthy controls were collected and their genomic DNAs were extracted. The polymorphism of CTLA-4 318 T / C,CT60 G / A and + 49 G / A were detected by direct sequencing after PCR. Meanwhile,the peripheral blood mononuclear cells( PBMCs)were isolated by the density gradient centrifugation,and their proliferation activity was detected by MTT assay. In addition,serum IL-2,IL-4,and TGF-β levels from cervical cancer patients and healthy controls were detected by ELISA. Results Compared with CTLA-4 genotype 318 TT,CC decreased the onset risk of cervical cancer obviously( χ^2= 7. 440,P〈0. 05). Compared with CTLA-4genotype CT60 GG,AA also significantly decreased the onset risk of cervical cancer( χ^2= 12. 165,P〈0. 05). The carriers with CTLA-4 318 T and CT60 G alleles suffered from cervical cancer more than those without significantly( χ^2= 13. 482 and 14. 138,P〈0. 05). However,the polymorphism of CTLA-4 + 49 G / A was not related to the onset risk of cervical cancer. There was significant difference in the proliferation of PBMCs between the carriers with CTLA-4 318 TT,TC and CC( F = 13. 842,P〈0. 05),while there was no any difference in that between the carriers with CTLA-4 CT60 GG,GA and AA,and between those with CTLA-4 + 49 GG,GA and AA( F = 0. 578 and 0. 150,P〉0. 05). There were significant difference in serum IL-2,IL-4 and TGF-β levels between different genotypes of CLTA-4 318 T / C,CT60 G / A and + 49 G / A( P〈0. 05). In addition,the stratified analysis showed that the polymorphism of CTLA-4 318 T / C was related to the staging of cervical cancer( χ^2= 18. 555,P〈0. 05),but unrelated to the patient' s age,menopause,and HPV infection( χ^2= 6. 310,1. 362 and 4. 772,respectively,P〉0. 05). Conclusion The polymorphism of CTLA-4318 T / C may be related to the onset risk and development of cervical cancer,which might be correlated with the regulation of T cell proliferation and the secretion of TH-type cytokines.
出处 《临床检验杂志》 CAS CSCD 2015年第2期119-123,共5页 Chinese Journal of Clinical Laboratory Science
基金 四川省医学科学院.四川省人民医院博士基金(30305030569)
关键词 细胞毒T淋巴细胞相关抗原4 基因多态性 宫颈癌 细胞因子 cytotoxic T-lymphocyte-associated antigen-4 genetic polymorphism cervical cancer cytokine
  • 相关文献

参考文献11

  • 1杨剑虹,徐凤娟,王金湖,程旭,顾凤华.基因扩增及导流杂交技术检测人乳头状瘤病毒[J].临床检验杂志,2012,30(12):981-982. 被引量:2
  • 2Al-Shaikh GK, Almussaed EM, Fayed AA, et al. Knowledge of Sau- di female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine[J]. Saudi Med J, 2014,35 (10) :1223-1230.
  • 3毛华杰,王晓春.CTLA-4+49A/G基因多态性与结直肠癌易感性的荟萃分析[J].临床检验杂志,2014,32(6):454-456. 被引量:2
  • 4Zhao HY, Duan HX, Gu Y, Meta-analysis of the cytotoxic T- lymphocyte antigen 4 gene + 6230G/A polymorphism and cancerrlsk [ J ]. Clin Transl Oncol, 2014,16(10) :879-885.
  • 5Yan Q, Chen P, Lu A, et el. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis [J]. PLoSOne,2013,8(12): e83710.
  • 6Vaidya B, Pearce S. The emerging role of the CTLA-4 gene in autoim- mune endocrinopathies [ J 1. Eur J Endocrinol, 2004, 150 ( 5 ) : 619-626.
  • 7Mocellin S, Nitti D. CTLA-4 blockade and the renaissance of cancer immuuotherapy [ J ]. Biochim Biophys Acta, 2013, 1836 ( 2 ) : 187-196.
  • 8Xiong YH, He L, Fei J. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer [ J ]. Int Immunop- harmacol, 2014,18(1 ) : 71-76.
  • 9Lee YH, Song GG. A meta-analysis of the association between CTLA- 4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer[ J]. Neoplasma,2014,61 (4) : 481-490.
  • 10李华,周翊峰,郭红燕,孙瞳,章文华,林东昕.细胞毒性T淋巴细胞相关抗原4编码区49位点的基因多态性与宫颈癌遗传易感性的关系[J].中华肿瘤杂志,2011,33(9):681-684. 被引量:8

二级参考文献31

  • 1Ferlay JFB, Pisaniand P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
  • 2Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocr Metab, 1997, 82:4130- 4132.
  • 3Chert L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4:336-347.
  • 4Bekkers RL, Massuger LF, Buhen J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol, 2004, 14:95-105.
  • 5Guzman VB, Yambaltsev A, Goncalves-Primo A, et al. New approach reveals C1)28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet, 2008, 17:1838-1844.
  • 6Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxie T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 2008, 68:7025-7034.
  • 7Cozar JM, Romero JM, Aptsiauri N, et al. High incidence of CTLA-4 AA ( CT60 ) polymorphism in renal cell cancer. Hum Immunol, 2007, 68:698-704.
  • 8Ghaderi A, Yeganeh F, Kalantari T, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 2004, 86:1-7.
  • 9Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 1995, 270:985-988.
  • 10Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A, 2003, 100:8372-8377.

共引文献8

同被引文献49

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部